Market Overview:
The global Paget's disease treatment market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of Paget's disease, rising awareness about available treatments, and growing demand for better and more effective therapies. The global paget's disease treatment market is segmented on the basis of type into bisphosphonates, calcitonin analogues (salmon calcitonin), analgesics, calcium and vitamin D supplements. Bisphosphonates are currently the most commonly used drugs for treating Paget's disease and are expected to continue to dominate the market during the forecast period. Calcitonin analogues are also widely used for treating Paget's disease and are expected to experience high growth rates during the forecast period. Analgesics are also commonly prescribed for managing pain associated with Paget's disease while calcium and vitamin D supplements help in preventing bone loss caused by this condition. On the basis of application, hospitals account for a majority share of revenue in this market owing to their large patient population base as well as greater availability of funds for diagnosis and treatment procedures related to paget’s diseases . However, clinics are also emerging as important players in this market due their lower costs as well as increasing focus on preventive healthcare measures .
Product Definition:
Paget's disease is a chronic disorder that affects the bones. It is marked by excessive bone remodeling, which leads to an abnormal shape and weakened bones. Treatment may include medications to reduce inflammation and pain, and surgery to correct bone deformities.
Bisphosphonates:
Bisphosphonates are a group of medicines that help to strengthen the bones and slow down the bone degeneration process in patients with osteoporosis. They also assist in increasing density of bone and reducing its fragility. Osteoporosis is caused by loss of bone mineral (calcium) due to low levels or absence or production of hormones such as estrogen, testosterone, and growth hormone.
Calcitonin Analogues (Salmon Calcitonin):
Calcitonin is a hormone produced by the parafollicular cells of the thyroid gland in response to hypocalcaemia. It has been used as a drug for the treatment of hypercalcaemia (Chron’s disease) and hypocalcaemia (Paget’s disease) since it was first discovered in 1803.
Application Insights:
The others segment held the largest share of the paget's disease treatment market in 2017. This segment includes patients referred by general physicians, orthopedic surgeons and rheumatologists for further evaluation and management. The hospital application segment is expected to grow at a fastest rate during the forecast period owing to rising awareness among general physicians, primary healthcare providers as well as hospitals regarding this disease. Increasing number of research studies supporting its benefits are also expected to boost market growth over the forecast period.
Hospitals were estimated as the largest application segment due to increasing prevalence rates coupled with high expenditure on medical devices & equipment by government agencies such as National Health Service (NHS) in U.K.
Regional Analysis:
North America dominated the global paget's disease treatment market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for technologically advanced products are some of the factors responsible for its large share. Moreover, increasing R&D activities by various companies to develop novel drugs is also expected to contribute towards regional growth over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising geriatric population and prevalence of osteoporosis coupled with growing awareness about osteoarthritis treatment options in this region. Increasing number of product launches by key players such as Novo Nordisk; Pfizer Inc.; Merck & Co., Inc.; Sanofi; Roche Holding Ltd.
Growth Factors:
- Increasing incidence of Paget's disease
- Growing awareness about the disease among people
- Rising demand for better and effective treatment options for Paget's disease
- Availability of government funding for research on Paget's disease treatment
- Technological advancements in the field of medical science
Scope Of The Report
Report Attributes
Report Details
Report Title
Paget's Disease Treatment Market Research Report
By Type
Bisphosphonates, Calcitonin Analogues (Salmon Calcitonin), Analgesics, Calcium and Vitamin D Supplements
By Application
Hospitals, Clinic, Others
By Companies
Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Neopharma, Inc., Sanofi S.A., Allergan(AbbVie), Fresenius Kabi, Sun Pharmaceutical Industries, Ltd., Mallinckrodt Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Paget's Disease Treatment Market Report Segments:
The global Paget's Disease Treatment market is segmented on the basis of:
Types
Bisphosphonates, Calcitonin Analogues (Salmon Calcitonin), Analgesics, Calcium and Vitamin D Supplements
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis AG
- Mylan NV
- Teva Pharmaceutical Industries Ltd.
- Neopharma, Inc.
- Sanofi S.A.
- Allergan(AbbVie)
- Fresenius Kabi
- Sun Pharmaceutical Industries, Ltd.
- Mallinckrodt Pharmaceuticals
Highlights of The Paget's Disease Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bisphosphonates
- Calcitonin Analogues (Salmon Calcitonin)
- Analgesics
- Calcium and Vitamin D Supplements
- By Application:
- Hospitals
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Paget's Disease Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no cure for Paget's disease, but there are treatments that can help manage the symptoms. Treatment options may include surgery, radiation therapy, and chemotherapy.
Some of the major players in the paget's disease treatment market are Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Neopharma, Inc., Sanofi S.A., Allergan(AbbVie), Fresenius Kabi, Sun Pharmaceutical Industries, Ltd., Mallinckrodt Pharmaceuticals.
The paget's disease treatment market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Paget's Disease Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Paget's Disease Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Paget's Disease Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Paget's Disease Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Paget's Disease Treatment Market Size & Forecast, 2018-2028
4.5.1 Paget's Disease Treatment Market Size and Y-o-Y Growth
4.5.2 Paget's Disease Treatment Market Absolute $ Opportunity
Chapter 5 Global Paget's Disease Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Paget's Disease Treatment Market Size Forecast by Type
5.2.1 Bisphosphonates
5.2.2 Calcitonin Analogues (Salmon Calcitonin)
5.2.3 Analgesics
5.2.4 Calcium and Vitamin D Supplements
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Paget's Disease Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Paget's Disease Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Paget's Disease Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Paget's Disease Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Paget's Disease Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Paget's Disease Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Paget's Disease Treatment Market Size Forecast by Type
9.6.1 Bisphosphonates
9.6.2 Calcitonin Analogues (Salmon Calcitonin)
9.6.3 Analgesics
9.6.4 Calcium and Vitamin D Supplements
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Paget's Disease Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Paget's Disease Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Paget's Disease Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Paget's Disease Treatment Market Size Forecast by Type
10.6.1 Bisphosphonates
10.6.2 Calcitonin Analogues (Salmon Calcitonin)
10.6.3 Analgesics
10.6.4 Calcium and Vitamin D Supplements
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Paget's Disease Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Paget's Disease Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Paget's Disease Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Paget's Disease Treatment Market Size Forecast by Type
11.6.1 Bisphosphonates
11.6.2 Calcitonin Analogues (Salmon Calcitonin)
11.6.3 Analgesics
11.6.4 Calcium and Vitamin D Supplements
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Paget's Disease Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Paget's Disease Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Paget's Disease Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Paget's Disease Treatment Market Size Forecast by Type
12.6.1 Bisphosphonates
12.6.2 Calcitonin Analogues (Salmon Calcitonin)
12.6.3 Analgesics
12.6.4 Calcium and Vitamin D Supplements
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Paget's Disease Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Paget's Disease Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Paget's Disease Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Paget's Disease Treatment Market Size Forecast by Type
13.6.1 Bisphosphonates
13.6.2 Calcitonin Analogues (Salmon Calcitonin)
13.6.3 Analgesics
13.6.4 Calcium and Vitamin D Supplements
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Paget's Disease Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Paget's Disease Treatment Market: Competitive Dashboard
14.2 Global Paget's Disease Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis AG
14.3.2 Mylan NV
14.3.3 Teva Pharmaceutical Industries Ltd.
14.3.4 Neopharma, Inc.
14.3.5 Sanofi S.A.
14.3.6 Allergan(AbbVie)
14.3.7 Fresenius Kabi
14.3.8 Sun Pharmaceutical Industries, Ltd.
14.3.9 Mallinckrodt Pharmaceuticals
